These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 5113836)

  • 21. Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):376-82. PubMed ID: 4401084
    [No Abstract]   [Full Text] [Related]  

  • 22. Anticholinergic agents based on Ariëns' dual receptor site theory: nonester antagonists.
    Stubbins JF; Hudgins PM; Murphy DC; Dickerson TL
    J Pharm Sci; 1972 Mar; 61(3):470-2. PubMed ID: 5013391
    [No Abstract]   [Full Text] [Related]  

  • 23. Anticholinergic esters of 2,6-bis (methoxymethyl) pirid-4-ol.
    Hill DG; Jansen AB
    J Med Chem; 1969 Nov; 12(6):1101-2. PubMed ID: 5351457
    [No Abstract]   [Full Text] [Related]  

  • 24. Psychotomimetic drugs as anticholinergic agents. II. Quantum-mechanical study of molecular interaction potentials of 1-cyclohexylpiperidine derivatives with the cholinergic receptor.
    Weinstein H; Maayani S; Srebrenik S; Cohen S; Sokolovsky M
    Mol Pharmacol; 1973 Nov; 9(6):820-34. PubMed ID: 4762638
    [No Abstract]   [Full Text] [Related]  

  • 25. Studies on the relationship of binding affinity to psychoactive and anticholingergic potency of a group of psychotomimetic glycolates.
    Baumgold J; Abood LG; Aronstam R
    Brain Res; 1977 Mar; 124(2):331-40. PubMed ID: 843950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacologic evaluation of a new series of cholinergic antagonists containing an agonist moiety.
    Hudgins PM; Stubbins JF
    J Pharmacol Exp Ther; 1969 Apr; 166(2):237-42. PubMed ID: 4388418
    [No Abstract]   [Full Text] [Related]  

  • 27. Estimation of anticholinergic drug effects in mice by antagonism against pilocarpine-induced salivation.
    Richter W
    Acta Pharmacol Toxicol (Copenh); 1966; 24(2):243-54. PubMed ID: 6013093
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparative behavioral effects of several anticholinergic agents in rats.
    Pradhan SN; Roth T
    Psychopharmacologia; 1968; 12(4):358-66. PubMed ID: 5652217
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and anticholinergic properties of some N,N-disubstituted carbamodithioic acid 2-oxo-2-(phenylamino)ethyl esters.
    Caliş U; Ozkanli F; Dalkara S; Erol K; Ozdemir M
    Pharmazie; 1993 Dec; 48(12):945-6. PubMed ID: 8115441
    [No Abstract]   [Full Text] [Related]  

  • 30. Nerve mediated response of the guinea-pig colon in situ: activity of some anticholinergic drugs.
    Soldani G; Del Tacca M; Giacomelli A; Crema C
    Arch Int Pharmacodyn Ther; 1970 Oct; 187(2):329-35. PubMed ID: 5481485
    [No Abstract]   [Full Text] [Related]  

  • 31. Estimation of atropine and some anticholinergics chemically related to atropine, on the isolated rat jejunum.
    Sund RB
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):84. PubMed ID: 5314451
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of a new anticholinergic agent (SA-504) on motility of the gastrointestinal tract and the urinary bladder in cats.
    Tamaki H; Ikeo T; Harigaya S; Nakajima H
    Jpn J Pharmacol; 1973 Jun; 23(3):391-400. PubMed ID: 4541952
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of anticholinergic drugs on DRL performance of rhesus monkeys.
    McDonough JH
    Pharmacol Biochem Behav; 1982 Jul; 17(1):85-90. PubMed ID: 7122671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 5,5-diphenyl-2-(2'-piperidinoethyl)-1,3-dioxolane-4-one a new drug with potent spasmolytic activity.
    Mörsdorf K; Wengenroth H
    Pharmacology; 1970; 3(4):193-200. PubMed ID: 5440391
    [No Abstract]   [Full Text] [Related]  

  • 35. Spasmolytic activity of some newer quinazolones.
    Dua PR; Kohli RP; Kumar R; Bhargava KP
    Indian J Physiol Pharmacol; 1967 Jul; 11(3):107-11. PubMed ID: 4390906
    [No Abstract]   [Full Text] [Related]  

  • 36. Influences of cholinergic mechanisms on the function and turnover of brain dopamine.
    Andén NE; Bédard P
    J Pharm Pharmacol; 1971 Jun; 23(6):460-2. PubMed ID: 4397193
    [No Abstract]   [Full Text] [Related]  

  • 37. [Inhibitory effect of parasympatholytics on serum cholinesterase in vitro].
    Patocka J
    Cesk Farm; 1971 Nov; 20(9):347-8. PubMed ID: 4400169
    [No Abstract]   [Full Text] [Related]  

  • 38. Centrally acting cholinolytics and the choice behaviour of the rat.
    van der Poel AM
    Prog Brain Res; 1972; 36():127-38. PubMed ID: 4644023
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparison between the anti-muscarinic and ganglion blocking activities of several atropine-like drugs].
    Kumada S; Ono T; Yamaguchi I; Otsuka M
    Nihon Yakurigaku Zasshi; 1970; 66(6):607-17. PubMed ID: 4395348
    [No Abstract]   [Full Text] [Related]  

  • 40. [Anticholinergic effects depending on the chemical constitution of a series of tertiary and quaternary propylamine derivatives].
    Ehrhart G; Härtfelder G; Schmitt K
    Arzneimittelforschung; 1970 Aug; 20(8):1094-6. PubMed ID: 5536510
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.